Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock — Stella

Recruiting

Back to Septic Shock trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

Canada

The Ottawa Hospital (General Campus), Ottawa, Ontario

The Ottawa Hospital (Civic Campus), Ottawa, Ontario

Key details

Phase

Safety & dosing

Sponsor

Ottawa Hospital Research Institute

Collaborators

Canadian Institutes of Health Research (CIHR), Stem Cell Network

Enrollment target

~296 participants

Started

February 2024

Primary completion

September 2026

Age range

18 Years and older

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov